Inovalon — Q1 2020 Earnings Presentation
34 slides from Inovalon's earnings presentation, Apr 29, 2020
Slide 1: Q1 2020 Earnings Supplement
Q1 2020 Earnings Supplement April 29, 2020
Slide 2: Cautionary Note Regarding Forward-Looking Statement
Cautionary Note Regarding Forward-Looking Statement Certain statements contained in this presentation constitute forward-looking statements within the meaning of, and are intended to be covered by the safe harbor provisions of, Section 27A of the Securities Act of 1933, as amended, and Section 21E o
Slide 3: Contents
Contents 1 Overview 2 2020 Q1 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on April 29, 2020 pertaining to first quarter (Q1) of 2020 3 2020 Financial Guidance results and guidance. 4 Appendix 1: Reconciliations INOV Q1 2020 Earnings Supplement (4.29.
Slide 4: The Inovalon ONE Platform
Payers Pharmacies Pharmaceuticals Devices Diagnostics The Inovalon ONE® Platform Inovalon is a leading provider of cloud- based platforms empowering data-driven healthcare. Inovalon provides cloud-based, real-time Massive Advanced Intervention Data connectivity, analytics, intervention, and Data Ass
Slide 5: Empowering Data-Driven Healthcare In Scale
Empowering Data-Driven Healthcare In Scale The reach of Inovalon’s platform has grown to touch the vast majority of the United States, able to empower the market’s largest data-driven healthcare initiatives. 100s Health Plans, Providers, Life Sciences, Pharmacy, and Diagnostics Organizations 315M+ P
Slide 6: Executing on Strategy
Executing on Strategy Inovalon’s three strategy guideposts are Lead In Innovation, Become the Enablement Layer, and Land and Expand Efficiently. Inovalon Lead in Innovation Become the Enablement Layer Land and Expand Efficiently Bring to market the industry’s most Leverage the resulting capabilities
Slide 7: Cloud-Based Platform Approach
Cloud-Based Platform Approach Inovalon provides its solutions to the marketplace through the Inovalon ONE® Platform: an integrated, real-time cloud native platform which brings together the capabilities of extensive healthcare ecosystem connectivity, massive scale datasets, advanced analytics, and d
Slide 8: Massive Data Assets
Massive Data 56 MORE2 REGISTRY® DATASET GROWTH Assets 54 52 Patient Count Medical Event Count 50 Inovalon leverages massive datasets to 48 deliver differentiated capabilities to its clients. 46 44 These datasets are expanding rapidly. As of the 42 40 2 ® end of Q1 2020, the MORE Registry dataset 38
Slide 9: Benefits of Inovalon's Massive Primary-Source Dataset
Benefits of Inovalon’s Massive Primary-Source Dataset The significant size, extensive breadth of data types, historical duration, recency timeliness, and fully linkable primary- sourced nature of Inovalon’s datasets provides a uniquely rich, longitudinally matched real-world dataset able to empower
Slide 10: Highly Differentiated Within the Market
Highly Differentiated Within the Market A leader in providing cloud-based tools to support data-driven healthcare, Inovalon empowers clients to achieve their clinical quality and financial goals by bringing highly differentiated capabilities to bear – unavailable from any other platform provider. Ma
Slide 11: Cloud-Based Telehealth Offering
Cloud-Based Telehealth Offering On March 23, 2020, Inovalon announced the addition of telehealth capabilities within its cloud-based Inovalon ONE® Platform offering. Unlike other telehealth offerings within the marketplace, Inovalon’s capabilities enable clients to perform patient-specific data-driv
Slide 12: Cloud-Based Healthcare Data Lake Offering
Cloud-Based Healthcare Data Lake Offering On January 13, 2020, Inovalon announced the addition to its cloud-based solution offerings, a cloud-based healthcare data lake, with a five-year contract with a leading healthcare organization executed during Q4 2019. The cloud-based Healthcare Data Lake sol
Slide 13: Contents
Contents 1 Overview 2 2020 Q1 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on April 29, 2020 pertaining to first quarter (Q1) of 2020 3 2020 Financial Guidance results and guidance. 4 Appendix 1: Reconciliations INOV Q1 2020 Earnings Supplement (4.29.
Slide 14: Q1 2020 Financial Highlights
Subscription-Based Cash & Cash Q1 2020 Platform Revenue of Equivalents Financial $137.1M Balance of Representing Revenue Growth of Highlights $182.9M During Q1 2020 Inovalon’s revenue grew 13% 6% year-over-year to $154.2 million, and year-over-year subscription-based platform revenue grew 13% year-o
Slide 15: COVID-19 Planning, Response, and Impact
COVID-19 Planning, Response, and Impact • Transition to Remote Operations: Inovalon leveraged and implemented its pandemic plan in February 2020 and quickly transitioned well to remote operations. • Launch of Telehealth and Increased Demand for Connectivity: The Company accelerated its existing plan
Slide 16: Continued Solid Sales Performance
Continued Solid Sales Performance The Company continued to see strong demand during the first quarter. Total sales pipeline grew to a record high since the launch of the Inovalon ONE® Platform. Despite a degree of some demand delay, new sales were solid during the period. Q1 2020 total new sales Ann
Slide 17: Continued Growth Momentum
Continued Growth Momentum The strong market demand for Inovalon’s cloud-based platforms and data-empowered capabilities, together with the growing sophistication of sales and the increasing operating leverage of the Company’s technologies and business model, is continuing to drive both meaningful mo
Slide 18: Continued Salesforce Focus
Continued Salesforce Focus During the first quarter of 2020, Inovalon continued its focus on expanding the number, sophistication, and technology-lead nature of its salesforce and overall go-to-market process. The ongoing investment continues to demonstrate an expansion of sales opportunity count, s
Slide 19: Increasing Headcount Efficiency
Increasing Headcount Efficiency The Company’s transition to higher-valued cloud-based offerings leveraging increased connectivity, software automation, SaaS- based, and subscription-based offerings has witnessed a substantial corresponding decrease in headcount while concurrently expanding revenue a
Slide 20: Contents
Contents 1 Overview 2 2020 Q1 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on April 29, 2020 pertaining to first quarter (Q1) of 2020 3 2020 Financial Guidance results and guidance. 4 Appendix 1: Reconciliations INOV Q1 2020 Earnings Supplement (4.29.
Slide 21: Strong Subscription-Based Platform Adoption
Strong Subscription-Based Platform Adoption The graphic below illustrates the revenue offering mix, which includes the Company’s revised 2020 guidance range as updated on April 29, 2020. $672- $698 $642.4 ~10% 2016 – 2020G 11% ~5% 26% Subscription-Based CAGR $527.7 6% $449.4 11% $427.6 9% 12% 15% 19
Slide 22: Expected Quarterly Revenue Cadence
Expected Quarterly Revenue Cadence The following illustration outlines the Company’s current 2020 quarterly revenue cadence expectation as impacted by the COVID-19 crisis, which reflects 5% to 9% year-over-year organic revenue growth as updated on April 29, 2020. YoY Organic Quarterly Revenue Growth
Slide 23: Adjusted EBITDA
Adjusted EBITDA The graphic below illustrates the Company’s 2020 Adjusted EBITDA and Adjusted EBITDA margin guidance as updated on April 29, 2020. $221 - $231 $211 2016 – 2020G 23% CAGR $152 $109 $100 33% 33% 29% 23% 24% 2016 2017 2018 2019 2020G % of Revenue Note: CAGR calculations undertaken to th
Slide 24: Cash Flow From Operations
Cash Flow From Operations The graphic below illustrates the Company’s 2020 Cash Flow from Operations guidance as updated on April 29, 2020. 2 $160 - $175 2016 – 2020G 16% CAGR $106 $1041 $98 $93 $90 24% 22% 22% 17% 17% 2016 2017 2018 2019 2020G % of Revenue Note: CAGR calculations undertaken to the
Slide 25: CAPEX Returning Towards Historical Levels
CAPEX Returning Towards Historical Levels During the period Q3 2016 through Q1 2018, the Company elected to invest more than $40M into incremental development towards the launch of the Inovalon ONE® Platform. The period of this disproportional investment is now complete and is increasingly being har
Slide 26: Covenant-Lite Debt Leverage
Covenant-Lite Debt Leverage On April 2, 2018, the Company put in place a $980M seven-year term debt facility and $100M five-year revolving debt facility, collectively the credit facility. Proceeds were used, among other things, to pay off all of the Company’s existing debt obligations of $225M as we
Slide 27: Full Year 2020 Financial Guidance
Full Year 2020 Financial Guidance The Company is updating its full-year 2020 guidance based on the expected business impact from COVID-19. Previous 2020 Financial Updated 2020 Financial YoY Financial Metric Guidance Guidance Change Originally Provided February 19, 2020 Provided April 29, 2020 Revenu
Slide 28: Q2 2020 Financial Guidance
Q2 2020 Financial Guidance Inovalon is providing Q2 2020 guidance as provided below, indicating 0% to 4% year-over-year organic revenue growth. Q2 2020 Financial Financial Metric Guidance Revenue $157 million to $163 million Net Income 1 $0 million to $2 million Non-GAAP net income1 $16 million to $
Slide 29: Contents
Contents 1 Overview 2 2020 Q1 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on April 29, 2020 pertaining to first quarter (Q1) of 2020 3 2020 Financial Guidance results and guidance. 4 Appendix 1: Reconciliations INOV Q1 2020 Earnings Supplement (4.29.
Slide 30: Reconciliation of Forward-Looking Guidance Adjusted EBITDA
Reconciliation of Forward-Looking Guidance Adjusted EBITDA Inovalon defines Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) as net income or loss calculated in accordance with GAAP, adjusted for the impact of depreciation and amortization, other expense, net
Slide 31: Reconciliation of Forward-Looking Guidance Non-GAAP Net Income
Reconciliation of Forward-Looking Guidance Non-GAAP Net Income Inovalon defines Non-GAAP net income as net income or loss calculated in accordance with GAAP, adjusted to exclude tax-affected stock-based compensation expense, acquisition costs, restructuring expense, amortization of acquired intangib
Slide 32: Definitions
Definitions 1. Annual Recurring Revenue is defined as subscription-based revenue from existing clients plus outstanding intra-year renewals valued at an amount agreed upon in principal. 2. Annual Revenue Retention is defined as the percentage of revenue from engagements with existing clients in the
Slide 33: ACV, TCV and Bookings
ACV, TCV and Bookings Inovalon’s sales have significantly expanded and accelerated, supporting strong growth going forward. The Company started reporting its sales performance in 2018 by providing new sales Annual Contract Value (ACV) data, a metric reflecting the sum of the first 12 months of reven
Slide 34: Healthcare Empowered
Healthcare Empowered® © 2020 by Inovalon. All rights reserved.